Clinical and Microbiological Features of Fulminant Haemolysis Caused by Clostridium perfringens Bacteraemia: Unknown Pathogenesis

被引:11
作者
Suzaki, Ai [1 ]
Hayakawa, Satoshi [1 ]
机构
[1] Nihon Univ, Dept Pathol & Microbiol, Sch Med, 30-1 Ohyaguchi Kamicho,Itabashiku, Tokyo 1738610, Japan
关键词
Clostridium perfringens; bacteraemia; massive intravascular haemolysis (MIH); MASSIVE INTRAVASCULAR HEMOLYSIS; PERFRINGOLYSIN O; SEPTICEMIA; INTERLEUKIN-1; INFLAMMATION; INFECTIONS; INDUCTION; PATIENT; SEPSIS; TOXINS;
D O I
10.3390/microorganisms11040824
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Bacteraemia brought on by Clostridium perfringens has a very low incidence but is severe and fatal in fifty per cent of cases. C. perfringens is a commensal anaerobic bacterium found in the environment and in the intestinal tracts of animals; it is known to produce six major toxins: alpha-toxin, beta-toxin, epsilon-toxin, and others. C. perfringens is classified into seven types, A, B, C, D, E, F and G, according to its ability to produce alpha-toxin, enterotoxin, and necrotising enterotoxin. The bacterial isolates from humans include types A and F, which cause gas gangrene, hepatobiliary infection, and sepsis; massive intravascular haemolysis (MIH) occurs in 7-15% of C. perfringens bacteraemia cases, resulting in a rapid progression to death. We treated six patients with MIH at a single centre in Japan; however, unfortunately, they all passed away. From a clinical perspective, MIH patients tended to be younger and were more frequently male; however, there was no difference in the toxin type or genes of the bacterial isolates. In MIH cases, the level of theta-toxin in the culture supernatant of clinical isolates was proportional to the production of inflammatory cytokines in the peripheral blood, suggesting the occurrence of an intense cytokine storm. Severe and systemic haemolysis is considered an evolutionary maladaptation as it leads to the host's death before the bacterium obtains the benefit of iron utilisation from erythrocytes. The disease's extraordinarily quick progression and dismal prognosis necessitate a straightforward and expedient diagnosis and treatment. However, a reliable standard of diagnosis and treatment has yet to be put forward due to the lack of sufficient case analysis.
引用
收藏
页数:15
相关论文
共 65 条
  • [1] Clostridium perfringens sepsis following a molar pregnancy
    Adams, Brandi N.
    Lekovic, Jovana P.
    Robinson, Suzzette
    [J]. AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2014, 210 (01) : E13 - E14
  • [2] Plasma cytokines IL-6, IL-8, and IL-10 are associated with the development of acute respiratory distress syndrome in patients with severe traumatic brain injury
    Aisiku, Imo P.
    Yamal, Jose-Miguel
    Doshi, Pratik
    Benoit, Julia S.
    Gopinath, Shankar
    Goodman, Jerry C.
    Robertson, Claudia S.
    [J]. CRITICAL CARE, 2016, 20
  • [3] Induction of Colonic Regulatory T Cells by Indigenous Clostridium Species
    Atarashi, Koji
    Tanoue, Takeshi
    Shima, Tatsuichiro
    Imaoka, Akemi
    Kuwahara, Tomomi
    Momose, Yoshika
    Cheng, Genhong
    Yamasaki, Sho
    Saito, Takashi
    Ohba, Yusuke
    Taniguchi, Tadatsugu
    Takeda, Kiyoshi
    Hori, Shohei
    Ivanov, Ivaylo I.
    Umesaki, Yoshinori
    Itoh, Kikuji
    Honda, Kenya
    [J]. SCIENCE, 2011, 331 (6015) : 337 - 341
  • [4] Synergistic effects of alpha-toxin and perfringolysin O in Clostridium perfringens-mediated gas gangrene
    Awad, MM
    Ellemor, DM
    Boyd, RL
    Emmins, JJ
    Rood, JI
    [J]. INFECTION AND IMMUNITY, 2001, 69 (12) : 7904 - 7910
  • [5] Mortality in sepsis and septic shock in Europe, North America and Australia between 2009 and 2019-results from a systematic review and meta-analysis
    Bauer, Michael
    Gerlach, Herwig
    Vogelmann, Tobias
    Preissing, Franziska
    Stiefel, Julia
    Adam, Daniel
    [J]. CRITICAL CARE, 2020, 24 (01)
  • [6] Heme oxygenase-1 is a modulator of inflammation and vaso-occlusion in transgenic sickle mice
    Belcher, JD
    Mahaseth, H
    Welch, TE
    Otterbein, LE
    Hebbel, RP
    Vercellotti, GM
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 2006, 116 (03) : 808 - 816
  • [7] BRYANT AE, 1993, FEMS IMMUNOL MED MIC, V7, P321, DOI 10.1016/0928-8244(93)90053-7
  • [8] Cecilia Roustit, 2013, Case Rep Emerg Med, V2013, P948071, DOI 10.1155/2013/948071
  • [9] Heme in pathophysiology: a matter of scavenging, metabolism and trafficking across cell membranes
    Chiabrando, Deborah
    Vinchi, Francesca
    Fiorito, Veronica
    Mercurio, Sonia
    Tolosano, Emanuela
    [J]. FRONTIERS IN PHARMACOLOGY, 2014, 5 : 1 - 24
  • [10] Chinen Katsuya, 2020, Autops. Case Rep., V10, pe2020185, DOI 10.4322/acr.2020.185